ALEXIS SOTIS: Open Payments
NPI 1275009912 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,918 in 129 payments from 24 companies in 2025. Trend: 2023 $632 · 2024 $2,007 · 2025 $2,918
Food & beverage: $2,809Education: $110
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 17 | $389 |
| Galderma Laboratories, L.P. | 24 | $354 |
| Regeneron Healthcare Solutions, Inc. | 11 | $291 |
| ABBVIE INC. | 14 | $278 |
| Janssen Biotech, Inc. | 4 | $251 |
| Lilly USA, LLC | 7 | $230 |
| Incyte Corporation | 11 | $165 |
| Journey Medical Corporation | 1 | $159 |
| GENZYME CORPORATION | 4 | $132 |
| Organon LLC | 11 | $121 |
Products named: Bimzelx, DUPIXENT, NEMLUVIO, SKYRIZI, TREMFYA, OPZELURA, EBGLYSS, VTAMA.
Industry payments across AZ — which companies pay providers there.
